Plus Therapeutics (PSTV) P/E (2019 - 2026)
Plus Therapeutics (PSTV) P/E from Sep 30, 2019 to Jul 21, 2026. The TTM Plus Therapeutics (PSTV) P/E is -2.64. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Plus Therapeutics (PSTV)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.64 | -76.63% |
| 2025 | -11.30 | +41.74% |
| 2024 | -7.97 | +74.46% |
| 2023 | -4.57 | -18.49% |
| 2022 | -5.60 | -67.94% |
| 2021 | -17.48 | -71.97% |
| 2020 | -62.37 | -121.47% |
| 2019 | 290.50 | N/A |
Comparison Plus Therapeutics (PSTV) P/E with competitors
Plus Therapeutics (PSTV) P/E is -2.64.